TY - JOUR
T1 - β-Zone Parapapillary Atrophy and the Velocity of Glaucoma Progression
AU - Teng, Christopher C.
AU - De Moraes, Carlos Gustavo V.
AU - Prata, Tiago S.
AU - Tello, Celso
AU - Ritch, Robert
AU - Liebmann, Jeffrey M.
N1 - Funding Information:
Supported by the Catherine and Ephraim Gildor Research Fund of the New York Glaucoma Research Institute, New York, New York.
PY - 2010/5
Y1 - 2010/5
N2 - Purpose: β-Zone parapapillary atrophy (PPA) occurs more commonly in eyes with glaucoma. Rates of glaucomatous visual field (VF) progression in eyes with and without β-zone PPA at the time of baseline assessment were compared. Design: Retrospective, comparative study. Participants: Two hundred forty-five patients from the New York Glaucoma Progression Study. Methods: Subjects with glaucomatous optic neuropathy and repeatable VF loss were assessed for eligibility. Eyes with a Heidelberg Retina Tomograph II (HRT) examination, at least 5 visual field tests after the HRT in either eye, optic disc photographs, and <6 diopters of myopia were enrolled. β-Zone PPA was defined as a region of chorioretinal atrophy with visible sclera and choroidal vessels adjacent to the optic disc. Global rates of VF progression were determined by automated pointwise linear regression analysis. Univariate analysis included age, gender, ethnicity, central corneal thickness (CCT), refractive error, baseline mean deviation, baseline intraocular pressure (IOP), mean IOP, IOP fluctuation, disc area, rim area, rim area-to-disc area ratio, β-zone PPA area, β-zone PPA area-to-disc area ratio, and presence or absence of β-zone PPA. Main Outcome Measures: The relationship between β-zone PPA and the rate and risk of glaucoma progression. Results: Two hundred forty-five eyes of 245 patients (mean age, 69.6±12.3 years) were enrolled. The mean follow-up was 4.9±1.4 years and the mean number of VFs after HRT was 9.3±2.7. β-Zone PPA was present in 146 eyes (65%). Eyes with β-zone PPA progressed more rapidly (-0.84±0.8 dB/year) than eyes without it (-0.51±0.6 dB/year; P<0.01). Multivariate regression showed significant influence of mean IOP (hazard ratio [HR], 1.11; P<0.01), IOP fluctuation (HR, 1.17; P = 0.02), and presence of β-zone PPA (HR, 2.59; P<0.01) on VF progression. Moderate (0.5-1.5 dB/year; P = 0.01) and fast (>1.5 dB/year; P = 0.08) global rates of progression occurred more commonly in eyes with β-zone PPA than in eyes without it. Thinner CCT (<525 μm) had a weak but significant correlation with presence of β-zone PPA (κ = 0.13). Conclusions: Eyes with β-zone PPA are at increased risk for glaucoma progression and warrant close clinical surveillance. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
AB - Purpose: β-Zone parapapillary atrophy (PPA) occurs more commonly in eyes with glaucoma. Rates of glaucomatous visual field (VF) progression in eyes with and without β-zone PPA at the time of baseline assessment were compared. Design: Retrospective, comparative study. Participants: Two hundred forty-five patients from the New York Glaucoma Progression Study. Methods: Subjects with glaucomatous optic neuropathy and repeatable VF loss were assessed for eligibility. Eyes with a Heidelberg Retina Tomograph II (HRT) examination, at least 5 visual field tests after the HRT in either eye, optic disc photographs, and <6 diopters of myopia were enrolled. β-Zone PPA was defined as a region of chorioretinal atrophy with visible sclera and choroidal vessels adjacent to the optic disc. Global rates of VF progression were determined by automated pointwise linear regression analysis. Univariate analysis included age, gender, ethnicity, central corneal thickness (CCT), refractive error, baseline mean deviation, baseline intraocular pressure (IOP), mean IOP, IOP fluctuation, disc area, rim area, rim area-to-disc area ratio, β-zone PPA area, β-zone PPA area-to-disc area ratio, and presence or absence of β-zone PPA. Main Outcome Measures: The relationship between β-zone PPA and the rate and risk of glaucoma progression. Results: Two hundred forty-five eyes of 245 patients (mean age, 69.6±12.3 years) were enrolled. The mean follow-up was 4.9±1.4 years and the mean number of VFs after HRT was 9.3±2.7. β-Zone PPA was present in 146 eyes (65%). Eyes with β-zone PPA progressed more rapidly (-0.84±0.8 dB/year) than eyes without it (-0.51±0.6 dB/year; P<0.01). Multivariate regression showed significant influence of mean IOP (hazard ratio [HR], 1.11; P<0.01), IOP fluctuation (HR, 1.17; P = 0.02), and presence of β-zone PPA (HR, 2.59; P<0.01) on VF progression. Moderate (0.5-1.5 dB/year; P = 0.01) and fast (>1.5 dB/year; P = 0.08) global rates of progression occurred more commonly in eyes with β-zone PPA than in eyes without it. Thinner CCT (<525 μm) had a weak but significant correlation with presence of β-zone PPA (κ = 0.13). Conclusions: Eyes with β-zone PPA are at increased risk for glaucoma progression and warrant close clinical surveillance. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
UR - https://www.scopus.com/pages/publications/77951623240
U2 - 10.1016/j.ophtha.2009.10.016
DO - 10.1016/j.ophtha.2009.10.016
M3 - Article
C2 - 20132988
AN - SCOPUS:77951623240
SN - 0161-6420
VL - 117
SP - 909
EP - 915
JO - Ophthalmology
JF - Ophthalmology
IS - 5
ER -